Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death‐Ligand 1 Blockade: A Case Discussion and Review of the Literature
2020 ◽
Vol 25
(5)
◽
pp. 369-374
◽
Miruna Grecea
◽
Aurélien Marabelle
◽
Samy Ammari
◽
Christophe Massard
◽
Stéphane Champiat
2021 ◽
Vol 16
(8)
◽
pp. 1247-1249
Wendy A. Cooper
◽
Sylvie Lantuejoul
◽
Mari Mino-Kenudson
2020 ◽
Vol 15
(11)
◽
pp. 1773-1781
◽
Takehito Shukuya
◽
Vikas Ghai
◽
Joseph M. Amann
◽
Tamio Okimoto
◽
Konstantin Shilo
◽
...
2020 ◽
Vol 8
(22)
◽
pp. 1526-1526
Lanfang Zhang
◽
Mingjuan Zhang
◽
Jinxiu Xu
◽
Shan Li
◽
Yu Chen
◽
...
2018 ◽
Vol 10
(12)
◽
pp. 6711-6721
◽
Jingyi Chen
◽
Yusong Chen
◽
Fenglan Feng
◽
Cheng Chen
◽
Haikang Zeng
◽
...
2019 ◽
Vol 7
(S8)
◽
pp. S287-S287
Lejia Sun
◽
Huayu Yang
◽
Yilei Mao
Parmida Sadat Pezeshki
◽
Pouya Mahdavi Sharif
◽
Nima Rezaei
2017 ◽
Vol 123
(17)
◽
pp. 3291-3304
◽
Seth M. Pollack
◽
Qianchuan He
◽
Jennifer H. Yearley
◽
Ryan Emerson
◽
Marissa Vignali
◽
...
Satoshi Yamashita
◽
Hiroyuki Abe
◽
Akiko Kunita
◽
Hiroharu Yamashita
◽
Yasuyuki Seto
◽
...
2021 ◽
Vol 2
(4)
◽
pp. 100149
Samuel A. Kareff
◽
Suraj Samtani
◽
Mauricio Burotto
◽
Vinay Prasad
◽
Chul Kim
2020 ◽
Vol 1
(4)
◽
pp. 100074
◽
Biagio Ricciuti
◽
Abdul Rafeh Naqash
◽
Jarushka Naidoo
◽
Kartik Sehgal
◽
Adam Miller
◽
...
Close
Export Citation Format
Close
Share Document
Close